The African Development Bank is providing financing to support the establishment of continental vaccine manufacturing hubs in Africa.
5 reports, 1 independent
Updated Aug 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The African Development Bank is providing financing to support the establishment of continental vaccine manufacturing hubs in Africa.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Africa
continent
-
African Development Bank
multilateral development finance institution
Related events
- Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.
- The African Union is advocating for equitable financing and a stronger voice for Africa on the global stage.
- African Union operates in Africa.
- Calls are being made for Pan-African collaboration in healthcare as various African nations, including South Africa, Nigeria, and Egypt, contribute to the continent's cancer burden.
- IDEXX Laboratories and Nyxoah, both healthcare companies, are distributing products in Africa.
Coverage
Newest first; wire copies grouped- africa-newsroom.comSouth Africa: African Development Bank and Biovac sign $15 million agreement to advance Africa's first end-to-end cholera vaccine production